HomeCompareIGPPF vs MRK

IGPPF vs MRK: Dividend Comparison 2026

IGPPF yields 15.46% · MRK yields 2.81%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 IGPPF wins by $8950348.50M in total portfolio value
10 years
IGPPF
IGPPF
● Live price
15.46%
Share price
$9.25
Annual div
$1.43
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$8950348.56M
Annual income
$8,840,493,512,154.56
Full IGPPF calculator →
MRK
Merck & Co. Inc.
● Live price
2.81%
Share price
$118.10
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$57.7K
Annual income
$10,113.78
Full MRK calculator →

Portfolio growth — IGPPF vs MRK

📍 IGPPF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodIGPPFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, IGPPF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
IGPPF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

IGPPF
Annual income on $10K today (after 15% tax)
$1,314.05/yr
After 10yr DRIP, annual income (after tax)
$7,514,419,485,331.38/yr
MRK
Annual income on $10K today (after 15% tax)
$238.95/yr
After 10yr DRIP, annual income (after tax)
$8,596.71/yr
At 15% tax rate, IGPPF beats the other by $7,514,419,476,734.66/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of IGPPF + MRK for your $10,000?

IGPPF: 50%MRK: 50%
100% MRK50/50100% IGPPF
Portfolio after 10yr
$4475174.31M
Annual income
$4,420,246,761,134.17/yr
Blended yield
98.77%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

IGPPF
No analyst data
Altman Z
5.0
Piotroski
6/9
MRK
Analyst Ratings
24
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+8.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

IGPPF buys
0
MRK buys
8
PoliticianChamberTickerTypeAmountDate
Josh Gottheimer🏢 House$MRK▲ Buy$1,001 - $15,0002026-02-04
Michael McCaul🏢 House$MRK▼ Sell$15,001 - $50,0002026-01-13
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-12-19
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-29
Val Hoyle🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-23
Marjorie Taylor Greene🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-28
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-08-14
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-05
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricIGPPFMRK
Forward yield15.46%2.81%
Annual dividend / share$1.43$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%32.7%
Portfolio after 10y$8950348.56M$57.7K
Annual income after 10y$8,840,493,512,154.56$10,113.78
Total dividends collected$8943002.90M$29.8K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: IGPPF vs MRK ($10,000, DRIP)

YearIGPPF PortfolioIGPPF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$13,792$3,091.89$11,213$373.04+$2.6KIGPPF
2$22,728$7,970.66$12,667$512.06+$10.1KIGPPF
3$48,870$24,551.48$14,439$708.14+$34.4KIGPPF
4$150,967$98,675.44$16,640$988.16+$134.3KIGPPF
5$731,293$569,758.23$19,432$1,394.07+$711.9KIGPPF
6$5,941,259$5,158,775.51$23,057$1,992.90+$5.92MIGPPF
7$84,696,516$78,339,369.42$27,889$2,894.79+$84.67MIGPPF
8$2,178,062,254$2,087,436,982.11$34,518$4,286.29+$2178.03MIGPPF
9$102,668,270,831$100,337,744,218.39$43,912$6,494.35+$102668.23MIGPPF
10$8,950,348,561,943$8,840,493,512,154.56$57,714$10,113.78+$8950348.50MIGPPF

IGPPF vs MRK: Complete Analysis 2026

IGPPFStock

Impellam Group plc provides staffing solutions, human capital management, and outsourced people-related services in the United Kingdom, North America, rest of Europe, and Australasia. It operates through four segments: Global Managed Services, STEM, Regional Specialist Staffing, and Healthcare. The Global Managed Services segment engages in the design, implement, coordinate, and report on the talent acquisition process through the provision of multi-disciplinary outsourced recruitment services under the Comensura, Guidant Global, and Flexy brand names. The STEM provides specialist contract and permanent recruitment services of scientists, clinicians, engineers, IT, and digital specialists under the Lorien, Carbon60, Bartech, and SRG brand names. The Regional Specialist Staffing segment offers staffing services for warehouse workers, secretaries, call centre operatives, lawyers, drivers, teachers, chefs, and HR and marketing professionals under the Blue Arrow, Tate, Career Teacher, and Chadwick Nott brand names. The Healthcare segment provides healthcare workforce solutions, including healthcare staffing, managed services, staff bank, occupational health, insourcing, social care, and home care services under the Medacs Healthcare, Global Medics, and Litmus Workforce Solutions brand names. This segment also recruits locum, temporary and permanent doctors, nurses, care workers, and allied health professionals. The company was incorporated in 2008 and is based in Luton, the United Kingdom.

Full IGPPF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this IGPPF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

IGPPF vs SCHDIGPPF vs JEPIIGPPF vs OIGPPF vs KOIGPPF vs MAINIGPPF vs JNJIGPPF vs ABBVIGPPF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.